The Business Research Company’s Biologic & Biosimilar RA Drugs Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Biologic & Biosimilar RA Drugs Global Market Report 2023 evaluates biologic & biosimilar RA drugs market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9255&type=smp
The global biologic & biosimilar RA drugs market size is expected to grow from $12.08 billion in 2022 to $12.65 billion in 2023 at a compound annual growth rate (CAGR) of 4.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biologic & biosimilar RA drugs market size is expected to grow to $15.19 billion in 2027 at a CAGR of 4.7%.
North America was the largest region in the biologic & biosimilar RA drugs market in 2022.
The biologic & biosimilar RA drugs market segments in the report are:
By Source:
Microbial
Mammalian
Other Sources
By Disease:
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Other Diseases
By Manufacturing:
Outsourced
In-House
By Mode Of Purchase:
Prescription Drugs
Over-The-Counter (OTC) Drugs
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Top Major Companies
Get More Information On The Biologic & Biosimilar RA Drugs Market Report:
The table of contents in TBRC’s biologic & biosimilar RA drugs market report includes:
- Executive Summary
- Biologic & Biosimilar RA Drugs Market Characteristics
- Biologic & Biosimilar RA Drugs Market Trends And Strategies
- Biologic & Biosimilar RA Drugs Market – Macro Economic Scenario
- Biologic & Biosimilar RA Drugs Market Size And Growth
……………………..
- Africa Biologic & Biosimilar RA Drugs Market
- Biologic & Biosimilar RA Drugs Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Biologic & Biosimilar RA Drugs Market
- Biologic & Biosimilar RA Drugs Market Future Outlook and Potential Analysis
- Appendix
…………………………..
List Of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Biologic & Biosimilar RA Drugs Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Biologic & Biosimilar RA Drugs Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Biologic & Biosimilar RA Drugs Market, Segmentation By Manufacturing, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
………………………..
Table 48: Samsung BioLogics Co. Ltd. Financial Performance
Table 49: Amgen Inc. Financial Performance
Table 50: Novo Nordisk A/S Financial Performance
Table 51: AbbVie Inc. Financial Performance
Table 52: Sanofi Pasteur Financial Performance
Read Related Reports
https://goodprnews.com/global-airport-stands-equipment-market-size/
https://goodprnews.com/aptamers-market-share/
https://goodprnews.com/ascorbic-acid-market-analysis/
https://topprnews.com/global-airport-stands-equipment-market-outlook/
https://topprnews.com/aptamers-market-trends/
https://topprnews.com/ascorbic-acid-market-growth/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
